Volume 5 Supplement 1

Proceedings of the Birmingham Cancer Epigenetics Conference; Translational Opportunities

Meeting abstracts

Edited by Ciaran Woodman, Bryan Turner, Constanze Bonnifer, Jennifer Anderton, Sarah Leonard and Lynn Thompson

Birmingham Cancer Epigenetics Conference; Translational Opportunities.

Birmingham, UK16 May 2013

Concatenated PDF 5S1

The dinucleotide CG as a genomic signalling module

Authors: Adrian Bird

Citation: Clinical Epigenetics 2013 5(Suppl 1):S1

Content type: Meeting abstract Published on: 19 August 2013
- View Full Text
- View PDF
FGF signalling inhibition in ESCs drives rapid genome-wide demethylation to the epigenetic ground state of pluripotency

Authors: Gabriella Ficz, Timothy A Hore, Fatima Santos, Heather J Lee, Wendy Dean, Julia Arand, Felix Krueger, David Oxley, Yu-Lee Paul, Jörn Walter, Simon J Cook, Simon Andrews, Miguel R Branco and Wolf Reik

Citation: Clinical Epigenetics 2013 5(Suppl 1):S2

Content type: Meeting abstract Published on: 19 August 2013
- View Full Text
- View PDF
Epigenetic modulation of distal regulatory elements in oral squamous cell carcinoma (OSCC)

Authors: Malgorzata Wiench, Songjoon Baek and Gordon Hager

Citation: Clinical Epigenetics 2013 5(Suppl 1):S3

Content type: Meeting abstract Published on: 19 August 2013
- View Full Text
- View PDF
Regulation of proliferation and survival of B-lymphocytes by Ebf1 - implications in leukaemia

Authors: Ildikó Győry and Rudolf Grosschedl

Citation: Clinical Epigenetics 2013 5(Suppl 1):S4

Content type: Meeting abstract Published on: 19 August 2013
- View Full Text
- View PDF
Cooperativity of imprinted genes inactivated by acquired chromosome 20q deletions

Authors: Athar Aziz, E Joanna Baxter, Carol Edwards, Clara Yujing Cheong, Mitsuteru Ito, Anthony Bench, Rebecca Kelley, Yvonne Silber, Philip A Beer, Keefe Chng, Marilyn B Renfree, Kirsten McEwen, Dionne Gray, Jyoti Nangalia, Ghulam J Mufti, Eva Hellstrom-Lindberg…

Citation: Clinical Epigenetics 2013 5(Suppl 1):S5

Content type: Meeting abstract Published on: 19 August 2013
- View Full Text
- View PDF
The role of BET epigenetic readers in acute myeloid leukaemia and other haematological malignancies

Authors: Brian Huntly

Citation: Clinical Epigenetics 2013 5(Suppl 1):S6

Content type: Meeting abstract Published on: 19 August 2013
- View Full Text
- View PDF
Understanding estrogen receptor transcription in breast cancer

Authors: Jason S Carroll

Citation: Clinical Epigenetics 2013 5(Suppl 1):S7

Content type: Meeting abstract Published on: 19 August 2013
- View Full Text
- View PDF
Comparative analysis of breast and colorectal tumours uncouples loss of DNA methylation in cancer from association with the nuclear periphery

Authors: Elizabeth Kerr, Richard R Meehan, Wendy A Bickmore and Duncan Sproul

Citation: Clinical Epigenetics 2013 5(Suppl 1):S8

Content type: Meeting abstract Published on: 19 August 2013
- View Full Text
- View PDF
Disruption of DNA methylation via S-adenosylhomocysteine is a key process in high incidence liver carcinogenesis

Authors: Leda Mirbahai, Tim D Williams, Guangliang Yin, Andrew D Southam, Ulf Sommer, Ning Li, John P Bignell, Brett P Lyons, Mark R Viant and James K Chipman

Citation: Clinical Epigenetics 2013 5(Suppl 1):S9

Content type: Meeting abstract Published on: 19 August 2013
- View Full Text
- View PDF
Genomic analysis reveals epigenetic ‘addiction’ underpinning follicular lymphoma and its transformation – a rationale for targeted epigenetic therapies

Authors: Jessica Okosun, Csaba Bödör, Jun Wang, Shamzah Araf, Claude Chelala and Jude Fitzgibbon

Citation: Clinical Epigenetics 2013 5(Suppl 1):S10

Content type: Meeting abstract Published on: 19 August 2013
- View Full Text
- View PDF
Histone deacetylase (HDAC) 1 and 2 are essential for normal T cell development and genomic stability in mice

Authors: Oliver M Dovey, George Vasilliou, Allan Bradley and Shaun M Cowley

Citation: Clinical Epigenetics 2013 5(Suppl 1):S11

Content type: Meeting abstract Published on: 19 August 2013
- View Full Text
- View PDF
Epigenetic therapies: novel strategies for improving outcomes in myeloid malignancies

Authors: Charles Craddock

Citation: Clinical Epigenetics 2013 5(Suppl 1):S12

Content type: Meeting abstract Published on: 19 August 2013
- View Full Text
- View PDF

Proceedings of the Birmingham Cancer Epigenetics Conference; Translational Opportunities

Meeting abstracts

The dinucleotide CG as a genomic signalling module

FGF signalling inhibition in ESCs drives rapid genome-wide demethylation to the epigenetic ground state of pluripotency

Epigenetic modulation of distal regulatory elements in oral squamous cell carcinoma (OSCC)

Regulation of proliferation and survival of B-lymphocytes by Ebf1 - implications in leukaemia

Cooperativity of imprinted genes inactivated by acquired chromosome 20q deletions

The role of BET epigenetic readers in acute myeloid leukaemia and other haematological malignancies

Understanding estrogen receptor transcription in breast cancer

Comparative analysis of breast and colorectal tumours uncouples loss of DNA methylation in cancer from association with the nuclear periphery

Disruption of DNA methylation via S-adenosylhomocysteine is a key process in high incidence liver carcinogenesis

Genomic analysis reveals epigenetic ‘addiction’ underpinning follicular lymphoma and its transformation – a rationale for targeted epigenetic therapies

Histone deacetylase (HDAC) 1 and 2 are essential for normal T cell development and genomic stability in mice

Epigenetic therapies: novel strategies for improving outcomes in myeloid malignancies

Follow

Clinical Epigenetics

Contact us